Biosimilar Market by Product (Monoclonal Antibodies, Recombinant Hormones, Immunomodulators, Anti-inflammatory Agents, and Others), Application (Oncology Diseases, Blood Disorders, Chronic & Autoimmune Diseases, Growth Hormone Deficiencies, and Others), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2021–2028
| Industry: Life Sciences | Report Code: LI2010580 | Pages: 170 | Tables: 50 | Publish Date : Jan 2022 |
- + 1-888-961-4454 Toll - Free
- +1 (917) 444-1262 - U.S
- + 91 7888029103 -Int'l
- support@researchdive.com
